Thomas H. Cartwright

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 10.9K citations · Full text

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

Frank A. Scappaticci, Louis Fehrenbacher, Thomas H. Cartwright et al. · Journal of Surgical Oncology · 2005 · 525 citations

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Aimery de Gramont, Eric Van Cutsem, Hans‐Joachim Schmoll et al. · The Lancet Oncology · 2012 · 522 citations

Gastrointestinal Oncology, Medicine, Colorectal Cancer +7

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Hans‐Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero et al. · Journal of Clinical Oncology · 2006 · 296 citations

Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic Cancer

Thomas H. Cartwright · Journal of Clinical Oncology · 2002 · 186 citations